EUVIMEDEUVIMED entdecken
Crossref

TTK Promotes Hepatic Fibrosis Through PKM2 / H3T11 ‐Mediated GLS1 ‐Dependent Glutamine Catabolism

Linying Lai iD, Zeyu Wang iD, Jianbin Zhang, Shiyi Chang, Jieru Chen, Cheng Guo iD, Jiangfeng Hu, Lingnan He, Bensong Duan

Liver International · 2026-12 · 46 (12)

DOI: 10.1111/liv.70893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 04.11.2026. Verfasst von Linying Lai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy Center, Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Liver Cirrhosis, Glutamine, Protein Serine-Threonine Kinases, Glutaminase. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, The Young Medical Talents Training Program of Shanghai Pudong New Area Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatic fibrosis represents a critical pathological process associated with substantial morbidity and mortality. Despite significant advances in understanding fibrogenesis, the molecular mechanisms driving fibrosis progression remain incompletely defined, and effective anti‐fibrotic therapies are still limited. This study aims to investigate the role of threonine tyrosine kinase (TTK) in hepatic fibrosis and uncover the underlying mechanisms involved.

Methods

Murine fibrosis models, HSC‐specific TTK knockout mice, and TTK inhibitors were employed to investigate the role of TTK in hepatic fibrosis. Fibrosis was evaluated by histological and biochemical assessments. Mix1 homeobox‐like 1 (MIXL1) was screened from RNA‐seq analysis and analysed by dual‐luciferase reporter assay. Mass spectrometry and Co‐immunoprecipitation identified TTK binding proteins. Metabolomics analysis and Seahorse analyser were performed to characterize glutamate metabolism and ATP production in HSC.

Results

TTK expression was elevated in patients with fibrosis and in CCl 4 —and TAA—induced fibrosis models. TTK silencing attenuated liver fibrosis in vitro and in vivo. Whereas TTK overexpression markedly exacerbated TGFβ‐induced fibrotic responses. Mechanistic investigations revealed TTK modulated glutamine catabolism in HSC. TTK inhibition impaired the integration of glutamate into the tricarboxylic acid cycle, thereby reducing ATP production required for HSC activation. Specifically, TTK upregulated transcription factor MIXL1 and transcriptionally activated GLS1, which was ultimately involved in HSC glutamine catabolism. Furthermore, TTK‐phosphorylated PKM2 translocated into the nucleus and phosphorylated histone H3 at threonine 11 (H3T11), facilitating MIXL1‐mediated transcriptional activation of GLS1.

Conclusions

These findings revealed a novel mechanism underlying the upregulation of GLS1 mediated by transcriptional control and highlighted TTK as a critical metabolic regulator in HSC activation and hepatic fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisGlutamineProtein Serine-Threonine KinasesGlutaminaseProtein-Tyrosine KinasesAnimalsMiceHumansMice, KnockoutHepatic Stellate CellsMaleCarrier ProteinsMice, Inbred C57BLMembrane ProteinsDisease Models, Animal

Stichwörter der Autor:innen

H3T11glutaminase 1 (GLS1)glutamine metabolismhepatic fibrosispyruvate kinase isozyme type M2 (PKM2)threonine tyrosine kinase (TTK)

Substanzen

GlutamineProtein Serine-Threonine KinasesGlutaminaseProtein-Tyrosine KinasesCarrier ProteinsMembrane Proteins

Autor:innen und Institutionen

  • Endoscopy Center, Department of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Gastroenterology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Advanced Research Institute, Tongji University, Shanghai, China.

ORCID-Profile: Linying Lai, Zeyu Wang, Cheng Guo

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • The Young Medical Talents Training Program of Shanghai Pudong New Area Health Commission
  • Pudong New Area Science and Technology Development Fund for Livelihood Research Special Project
  • The Shanghai "Rising Stars of Medical Talents" Youth Development Program

Zitieren

APA

Lai, L., Wang, Z., Zhang, J., Chang, S., Chen, J., Guo, C., Hu, J., He, L., & Duan, B. (2026). TTK Promotes Hepatic Fibrosis Through PKM2 / H3T11 ‐Mediated GLS1 ‐Dependent Glutamine Catabolism. Liver International, 46(12). https://doi.org/10.1111/liv.70893

Vancouver

Lai L, Wang Z, Zhang J, Chang S, Chen J, Guo C, et al. TTK Promotes Hepatic Fibrosis Through PKM2 / H3T11 ‐Mediated GLS1 ‐Dependent Glutamine Catabolism. Liver International. 2026;46(12). doi:10.1111/liv.70893

BibTeX
@article{Lai2026,
  author = {Lai, Linying and Wang, Zeyu and Zhang, Jianbin and Chang, Shiyi and Chen, Jieru and Guo, Cheng and Hu, Jiangfeng and He, Lingnan and Duan, Bensong},
  title = {TTK Promotes Hepatic Fibrosis Through PKM2 / H3T11 ‐Mediated GLS1 ‐Dependent Glutamine Catabolism},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {12},
  doi = {10.1111/liv.70893}
}
Kostenlos starten →